Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants-Reference-Cited by-同舟云学术

Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants

Published:2012-11-02 Issue:11 Volume:7 Page:e47725
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Vidal Francesc,López-Dupla Miguel,Laguno Montserrat,Veloso Sergi,Mallolas Josep,Murillas Javier,Cifuentes Carmen,Gallart Lluis,Auguet Teresa,Sampériz Gloria,Payeras Antoni,Hernandez Pilar,Arnedo Mireia,Gatell Josep Ma,Richart Cristóbal

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients;FJ Torriani;N Engl J Med,2004

2. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients;AA Butt;Clin Infect Dis,2012

3. Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients;M Pérez-Olmeda;AIDS,2003

4. Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin;M Laguno;J Acquir Immune Defic Syndr,2007

5. Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients;M Núñez;J Acquir Immune Defic Syndr,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WITHDRAWN: Analysis of host genetic variations associated with response to anti-HCV therapies in global populations;Meta Gene;2021-03

2. Methylation Pattern of the SOCS3 and IL6R Promoters in Rheumatoid Arthritis;International Journal of Inflammation;2020-03-31

3. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients;Infection, Genetics and Evolution;2018-12

4. Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients;Pharmacogenomics;2018-08-01

5. SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B;Oncotarget;2017-02-04